Your Health, We Care
Finerenone is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
来自FDA，2022.09
What is Finerenone?Finerenone contains the active ingredient Finerenone. This medicine is subject to additional monitoring to allow quick identification of new safety information. ···【more】
Article source：Lucius LaosRelease date：2026-05-06Recommended：53
Cardiovascular Effects of FinerenoneTwo large Phase III trials were conducted with finerenone in patients with chronic kidney disease and type 2 diabetes mellitus: FIGARO-DKD (N=73···【more】
Article source：Lucius LaosRelease date：2026-04-30Recommended：74
Mechanism of Action of FinerenoneFinerenone is indicated for the treatment of adult patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%, and for adult p···【more】
Article source：Lucius LaosRelease date：2026-04-30Recommended：74
Finerenone is applicable to chronic kidney disease related to type 2 diabetes.【more】
Article source：Lucius LaosRelease date：2026-01-06Recommended：106
This article analyzes the clinical application and economic cost of finerenone.What are the suitable populations for finerenone?The use of this drug should be strictly in accordanc···【more】
Article source：Lucius LaosRelease date：2025-04-15Recommended：249
According to the treatment needs of patients with specific chronic diseases, the application value of finerenone has gradually attracted attention.What diseases is finerenone suita···【more】
Article source：Lucius LaosRelease date：2025-04-15Recommended：228
In view of the application value and clinical practice of finerenone, this article reviews the key information.What are the indications for finerenoneThis drug has shown a unique r···【more】
Article source：Lucius LaosRelease date：2025-04-14Recommended：191
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
